rxstat › Shortages › Medronic Acid

Medronic Acid (Stannous Mdp, Draximage Mdp-25) shortage status

Widespread shortage Tier 3: critical

Source: Health Canada shortage reports · Updated Sep 17, 2026

Also sold as: Stannous Mdp, Draximage Mdp-25, Draximage Mdp

Medronic Acid is in a widespread shortage in Canada. 3 of 3 reported products are affected, and Health Canada has designated this a Tier 3 (most serious) shortage. The latest manufacturer estimate for full recovery is Feb 15, 2027.

Products affected

3 / 3

In shortage since

May 27, 2026

Est. full return

Feb 15, 2027

Reports on file

Talk to a pharmacist

Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.

Book a pharmacist appointment

Need your prescription switched?

When every manufacturer is affected, an online doctor can assess your situation and prescribe an alternative.

See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage

DRAXIMAGE MDP-25

25MG · POWDER FOR SOLUTION · JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA

DIN 02329239 · since May 27, 2026, est. end Feb 15, 2027 · Disruption of the manufacture of the drug.

Active shortage

DRAXIMAGE MDP

10MG · POWDER FOR SOLUTION · JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA

DIN 02329409 · since Jun 3, 2026, est. end Oct 15, 2026 · Disruption of the manufacture of the drug.

Active shortage

STANNOUS MDP KIT

15MG · KIT SOLUTION · CALGARY RADIOPHARMACEUTICAL CENTRE / ALBERTA HEALTH SERVICES

DIN 02485834 · since Jul 23, 2026, est. end Oct 31, 2026 · Shortage of an inactive ingredient or component.

Resolved

DRAXIMAGE MDP-25

25MG · POWDER FOR SOLUTION · JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA

DIN 02329239 · ended Dec 21, 2022

What's happening

Medronic Acid is currently affected by 3 active shortage reports filed with Health Canada by JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA, CALGARY RADIOPHARMACEUTICAL CENTRE / ALBERTA HEALTH SERVICES.

The reported causes are: disruption of the manufacture of the drug; shortage of an inactive ingredient or component. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

Health Canada has flagged this as a Tier 3 shortage, its most serious category, meaning the shortage has the greatest potential impact on the health system and alternatives are limited.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Recent changes

Sep 17, 2026 Estimated end date pushed back : Nov 30, 2026 → Feb 15, 2027
Sep 17, 2026 Estimated end date pushed back : Sep 30, 2026 → Oct 15, 2026
Sep 1, 2026 Estimated end date pushed back : Sep 23, 2026 → Oct 31, 2026
Aug 10, 2026 New report filed
Aug 10, 2026 New report filed
Aug 10, 2026 Tier 3 designation changed
Jul 31, 2026 New report filed

Common questions

When will Medronic Acid be back in stock in Canada?

The latest manufacturer estimate is Feb 15, 2027. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Medronic Acid in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Tetrasodium Pyrophosphate (Stannous Pyp) Widespread shortage 2 of 2 reported products affected · est. return Mar 31, 2027

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.